News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
595,883 Results
Type
Article (23280)
Company Profile (325)
Press Release (572272)
Multimedia
Podcasts (113)
Webinars (15)
Section
Business (197928)
Career Advice (619)
Deals (30482)
Drug Delivery (60)
Drug Development (72298)
Employer Resources (47)
FDA (12662)
Job Trends (11207)
News (290682)
Policy (22861)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1313)
Accelerated approval (44)
ADA (42)
Adcomms (18)
Allergies (155)
Alliances (42059)
ALS (212)
Alzheimer's disease (1516)
Antibody-drug conjugate (ADC) (513)
Approvals (13242)
Artificial intelligence (614)
ASCO (281)
Autoimmune disease (336)
Automation (39)
Bankruptcy (308)
Best Places to Work (8829)
BIO (65)
BIOSECURE Act (6)
Biosimilars (179)
Biotechnology (230)
Bladder cancer (171)
Brain cancer (62)
Breast cancer (715)
Cancer (5643)
Cardiovascular disease (429)
Career advice (542)
Career pathing (20)
CAR-T (334)
CDC (18)
Celiac Disease (1)
Cell therapy (905)
Cervical cancer (45)
Clinical research (64300)
Collaboration (2058)
Commercialization (1)
Company closure (3)
Compensation (1514)
Complete response letters (76)
COVID-19 (1479)
CRISPR (121)
C-suite (1126)
Cystic fibrosis (151)
Data (8047)
Decentralized trials (1)
Denatured (26)
Depression (164)
Dermatology (90)
Diabetes (543)
Diagnostics (5152)
Digital health (47)
Diversity (8)
Diversity, equity & inclusion (12)
Drug discovery (348)
Drug pricing (68)
Drug shortages (8)
Duchenne muscular dystrophy (317)
Earnings (81070)
Editorial (46)
Employer branding (7)
Employer resources (46)
Events (105320)
Executive appointments (998)
FDA (16226)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (23)
Frontotemporal dementia (36)
Funding (1657)
Gene editing (260)
Generative AI (47)
Gene therapy (725)
GLP-1 (740)
Government (1904)
Grass and pollen (4)
Guidances (349)
Healthcare (12565)
Hematology (153)
HIV (68)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (110)
Immunology and inflammation (278)
Immuno-oncology (100)
Indications (207)
Infectious disease (1747)
Inflammatory bowel disease (207)
Inflation Reduction Act (12)
Influenza (101)
Intellectual property (303)
Interviews (90)
IPO (14549)
IRA (16)
Job creations (2741)
Job search strategy (474)
JPM (50)
Kidney cancer (19)
Labor market (67)
Layoffs (353)
Leadership (19)
Legal (5832)
Liver cancer (69)
Longevity (29)
Lung cancer (751)
Lymphoma (415)
Machine learning (50)
Management (15)
Manufacturing (845)
Marketing (7)
MASH (191)
Medical affairs (1)
Medical device (10435)
Medtech (10586)
Mergers & acquisitions (17142)
Metabolic disorders (1316)
mRNA (188)
Multiple sclerosis (164)
NASH (14)
Neurodegenerative disease (437)
Neuropsychiatric disorders (100)
Neuroscience (3018)
Neurotech (1)
NextGen: Class of 2026 (4412)
Non-profit (1628)
Now hiring (55)
Obesity (543)
Opinion (166)
Ovarian cancer (225)
Pain (237)
Pancreatic cancer (329)
Parkinson's disease (372)
Partnered (35)
Patents (581)
Patient recruitment (747)
Peanut (57)
People (50324)
Pharmaceutical (53)
Pharmacy benefit managers (15)
Phase 1 (21132)
Phase 2 (28949)
Phase 3 (19923)
Pipeline (9191)
Policy (145)
Postmarket research (1932)
Preclinical (9009)
Press Release (54)
Prostate cancer (293)
Psychedelics (70)
Radiopharmaceuticals (340)
Rare diseases (1101)
Real estate (4005)
Recruiting (20)
Regulatory (19879)
Reports (34)
Research institute (1391)
Resumes & cover letters (87)
Rett syndrome (46)
RNA editing (31)
RSV (57)
Schizophrenia (170)
Series A (299)
Series B (218)
Service/supplier (4)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (146)
Sponsored (27)
Startups (3207)
State (1)
Stomach cancer (8)
Supply chain (77)
Tariffs (23)
The Weekly (85)
Vaccines (613)
Venture capital (103)
Weight loss (294)
Women's health (100)
Worklife (6)
Date
Today (82)
Last 7 days (393)
Last 30 days (1702)
Last 365 days (27091)
2026 (15274)
2025 (26958)
2024 (31203)
2023 (34720)
2022 (44106)
2021 (46543)
2020 (41922)
2019 (31178)
2018 (23354)
2017 (25740)
2016 (23858)
2015 (29627)
2014 (25412)
2013 (21097)
2012 (22889)
2011 (23186)
2010 (22789)
Location
Africa (436)
Alabama (87)
Alaska (4)
Arizona (329)
Arkansas (14)
Asia (30257)
Australia (4677)
California (13541)
Canada (3734)
China (1325)
Colorado (564)
Connecticut (582)
Delaware (385)
Europe (57289)
Florida (1970)
Georgia (418)
Hawaii (3)
Idaho (49)
Illinois (972)
India (79)
Indiana (461)
Iowa (20)
Japan (565)
Kansas (113)
Kentucky (40)
Louisiana (50)
Maine (38)
Maryland (1448)
Massachusetts (9893)
Michigan (319)
Minnesota (638)
Mississippi (5)
Missouri (103)
Montana (32)
Nebraska (18)
Nevada (129)
New Hampshire (84)
New Jersey (3320)
New Mexico (18)
New York (3358)
North Carolina (1635)
North Dakota (9)
Northern California (6884)
Ohio (345)
Oklahoma (15)
Oregon (37)
Pennsylvania (2664)
Puerto Rico (26)
Rhode Island (42)
South America (652)
South Carolina (78)
South Dakota (1)
Southern California (5374)
Tennessee (147)
Texas (2143)
United States (46327)
Utah (396)
Vermont (1)
Virginia (250)
Washington D.C. (56)
Washington State (1090)
West Virginia (3)
Wisconsin (126)
595,883 Results for "x biotix therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces
March 17, 2026
·
3 min read
Press Releases
Kali Therapeutics Announces Poster Presentation of KT209, a Novel CD19 x CD20 x CD3 Trispecific Antibody, at the EHA 2026 Annual Congress
June 8, 2026
·
3 min read
Press Releases
Seres Therapeutics to Present at CARB-X Investor Day
April 9, 2026
·
6 min read
Business
PRECISIO BIOTIX THERAPEUTICS ANNOUNCES COLLABORATION WITH MAYO CLINIC
Precisio Biotix Therapeutics (“Precisio”) today announced it has entered into an agreement with Mayo Clinic.
March 14, 2024
·
3 min read
Press Releases
Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis
June 22, 2026
·
5 min read
Press Releases
CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome
June 10, 2026
·
6 min read
Press Releases
Precisio Biotix Therapeutics, Inc. (Precisio) Announces a Grant for the Discovery of Novel Engineered Lysin Antimicrobials Targeting Bacterial Vaginosis Associated Pathobionts (BV)
June 16, 2025
·
3 min read
Press Releases
Precisio Biotix Therapeutics, Inc. (Precisio) Announces Dosing of a First Patient with ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection
July 3, 2025
·
3 min read
Press Releases
Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa
May 21, 2026
·
7 min read
Deals
Precisio Biotix Therapeutics Acquires London-Headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists
Precisio Biotix Therapeutics announced the acquisition of CC Bio, creator of the ZEUS anti-bacterial lysin platform.
March 1, 2024
·
4 min read
1 of 59,589
Next
